Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
3
×
life sciences
national blog main
national top stories
san francisco
san francisco blog main
san francisco top stories
third rock ventures
warp drive bio
3
×
cancer
cancer drugs
clinical trials
deals
revolution medicines
sanofi
the column group
acetylon pharmaceuticals
ambys medicines
amgen
cell therapy
cobimetinib
colorectal cancer
constellation pharmaceuticals
gene therapy
genentech
holger willenbring
investing
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
mark goldsmith
markus grompe
martin burke
new york blog main
new york top stories
non-small cell lung cancer
What
medicines
3
×
cancer
ipo
proteins
research
revolution
aiming
ambys
big
biotech
cancer’s
control
deadly
deal
debuted
despite
disease
diseases
drug
family
formed
frontiers
future
hardest
hit
hottest
hunters
known
launch
liver
make
maps
new
parlance
pharmaceutical
play
ras
reach
reels
revealed
Language
unset
Current search:
medicines
×
ipo
×
" warp drive bio "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
